Abstract

Sensitive and reliable diagnostic test systems based on real-time PCR are of great importance in the fight against the ongoing SARS-CoV-2 pandemic. The genetic variability of the SARS-CoV-2 virus leads to the accumulation of mutations, some of which may affect the sensitivity of modern PCR assays. The aim of this study was to search in Russian clinical samples for new mutations in SARS-CoV-2 gene N that can affect the detection by RT-PCR. In this study, the polymorphisms in the regions of the target gene N causing failed or poor detection of the target N in the RT-PCR assay on 12 selected samples were detected. Sequencing the entire N and E genes in these samples along with other 195 samples that were positive for both target regions was performed. Here, we identified a number of nonsynonymous mutations and one novel deletion in the N gene that affected the ability to detect a target in the N gene as well a few mutations in the E gene of SARS-CoV-2 that did not affect detection. Sequencing revealed that majority of the mutations in the N gene were located in the variable region between positions 193 and 235 aa, inside and nearby the phosphorylated serine-rich region of the protein N. This study highlights the importance of the further characterization of the genetic variability and evolution of gene N, the most common target for detecting SARS-CoV-2. The use of at least two targets for detecting SARS-CoV-2, including one for the E gene, will be necessary for reliable diagnostics.

Highlights

  • The novel coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 virus, is still a major threat to health

  • In the laboratory testing for detecting SARS-CoV-2, reverse transcriptase real-time PCR (RT-qPCR) assays have played a pivotal role in combating the ongoing coronavirus disease 2019 (SARS-COVID-19) spread

  • The genetic variability of the SARS-CoV-2 virus leads to the accumulation of mutations in the target regions used in modern diagnostic test systems for detecting SARS-CoV-2

Read more

Summary

Introduction

The novel coronavirus disease 2019 (COVID-19) pandemic, caused by the SARS-CoV-2 virus, is still a major threat to health. In the laboratory testing for detecting SARS-CoV-2, reverse transcriptase real-time PCR (RT-qPCR) assays have played a pivotal role in combating the ongoing coronavirus disease 2019 (SARS-COVID-19) spread. Since the start of the COVID-19 outbreak, various RT-qPCR assays have been developed. Commercial assays targeting mainly SARS-CoV-2 nucleocapsid (N), small envelope (E), and RdRp genes have been developed [1]. Gene N is the most commonly used SARS-CoV-2 detection target for viral diagnosis [2,3]. Gene N is expressed at a high level compared with other viral protein genes after infection with SARS-CoV-2 [5], which makes it a preferred target for the detection of SARS-CoV-2

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call